

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.73894847 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 4.02576706 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.02576706 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 3.79190310 |
| 5 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.79190310 |
| 6 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.69041787 |
| 7 | alpha-linolenic acid metabolic process (GO:0036109) | 3.65247270 |
| 8 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 3.62153298 |
| 9 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.51903871 |
| 10 | muscle filament sliding (GO:0030049) | 3.46385091 |
| 11 | actin-myosin filament sliding (GO:0033275) | 3.46385091 |
| 12 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.37444527 |
| 13 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.33308930 |
| 14 | lysine metabolic process (GO:0006553) | 3.32484249 |
| 15 | lysine catabolic process (GO:0006554) | 3.32484249 |
| 16 | aromatic amino acid family catabolic process (GO:0009074) | 3.26659163 |
| 17 | glutamate metabolic process (GO:0006536) | 3.22632258 |
| 18 | actin-mediated cell contraction (GO:0070252) | 3.15975194 |
| 19 | regulation of cholesterol homeostasis (GO:2000188) | 3.10701041 |
| 20 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.09643717 |
| 21 | plasma membrane repair (GO:0001778) | 3.07368070 |
| 22 | regulation of ARF protein signal transduction (GO:0032012) | 3.05550724 |
| 23 | bile acid biosynthetic process (GO:0006699) | 3.03692964 |
| 24 | cysteine metabolic process (GO:0006534) | 3.01516408 |
| 25 | regulation of cell communication by electrical coupling (GO:0010649) | 3.01250770 |
| 26 | regulation of relaxation of muscle (GO:1901077) | 2.99781477 |
| 27 | cerebellar granule cell differentiation (GO:0021707) | 2.98900615 |
| 28 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.96046695 |
| 29 | short-chain fatty acid metabolic process (GO:0046459) | 2.95441557 |
| 30 | cellular ketone body metabolic process (GO:0046950) | 2.94406886 |
| 31 | sulfur amino acid catabolic process (GO:0000098) | 2.93345170 |
| 32 | kynurenine metabolic process (GO:0070189) | 2.92776071 |
| 33 | fatty acid transmembrane transport (GO:1902001) | 2.92085162 |
| 34 | cellular potassium ion homeostasis (GO:0030007) | 2.91696255 |
| 35 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.91543701 |
| 36 | high-density lipoprotein particle remodeling (GO:0034375) | 2.90939266 |
| 37 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.88049477 |
| 38 | skeletal muscle contraction (GO:0003009) | 2.87598055 |
| 39 | actin filament-based movement (GO:0030048) | 2.86291327 |
| 40 | reverse cholesterol transport (GO:0043691) | 2.84923176 |
| 41 | 2-oxoglutarate metabolic process (GO:0006103) | 2.84439607 |
| 42 | protein carboxylation (GO:0018214) | 2.83771311 |
| 43 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.83771311 |
| 44 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 2.83546886 |
| 45 | amino-acid betaine metabolic process (GO:0006577) | 2.80995458 |
| 46 | urea cycle (GO:0000050) | 2.79208451 |
| 47 | urea metabolic process (GO:0019627) | 2.79208451 |
| 48 | cytoplasmic mRNA processing body assembly (GO:0033962) | 2.79192028 |
| 49 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.78858548 |
| 50 | aspartate family amino acid catabolic process (GO:0009068) | 2.77377301 |
| 51 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.76290999 |
| 52 | carnitine shuttle (GO:0006853) | 2.75968771 |
| 53 | myofibril assembly (GO:0030239) | 2.75548169 |
| 54 | vesicle transport along microtubule (GO:0047496) | 2.74788537 |
| 55 | skin morphogenesis (GO:0043589) | 2.74253914 |
| 56 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 2.73903099 |
| 57 | hypotonic response (GO:0006971) | 2.73693929 |
| 58 | striated muscle contraction (GO:0006941) | 2.72407097 |
| 59 | dicarboxylic acid catabolic process (GO:0043649) | 2.71707859 |
| 60 | acylglycerol homeostasis (GO:0055090) | 2.71292734 |
| 61 | triglyceride homeostasis (GO:0070328) | 2.71292734 |
| 62 | bile acid metabolic process (GO:0008206) | 2.71014281 |
| 63 | negative regulation of dendrite morphogenesis (GO:0050774) | 2.70200077 |
| 64 | sodium ion export (GO:0071436) | 2.67875989 |
| 65 | cardiac muscle contraction (GO:0060048) | 2.67656886 |
| 66 | positive regulation of glucose import (GO:0046326) | 2.67164900 |
| 67 | complement activation, alternative pathway (GO:0006957) | 2.67134196 |
| 68 | indole-containing compound catabolic process (GO:0042436) | 2.66949842 |
| 69 | indolalkylamine catabolic process (GO:0046218) | 2.66949842 |
| 70 | tryptophan catabolic process (GO:0006569) | 2.66949842 |
| 71 | relaxation of cardiac muscle (GO:0055119) | 2.66928478 |
| 72 | positive regulation of fatty acid oxidation (GO:0046321) | 2.66047811 |
| 73 | regulation of protein activation cascade (GO:2000257) | 2.65738752 |
| 74 | gamma-aminobutyric acid transport (GO:0015812) | 2.65167951 |
| 75 | glyoxylate metabolic process (GO:0046487) | 2.64520741 |
| 76 | regulation of bile acid biosynthetic process (GO:0070857) | 2.63055474 |
| 77 | cellular modified amino acid catabolic process (GO:0042219) | 2.62444115 |
| 78 | myotube differentiation (GO:0014902) | 2.61824098 |
| 79 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.61663112 |
| 80 | locomotory exploration behavior (GO:0035641) | 2.61662048 |
| 81 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.61464504 |
| 82 | homocysteine metabolic process (GO:0050667) | 2.60942419 |
| 83 | phospholipid homeostasis (GO:0055091) | 2.60287261 |
| 84 | regulation of transforming growth factor beta2 production (GO:0032909) | 2.59232733 |
| 85 | drug catabolic process (GO:0042737) | 2.58715102 |
| 86 | regulation of triglyceride catabolic process (GO:0010896) | 2.58095442 |
| 87 | alpha-amino acid catabolic process (GO:1901606) | 2.57687043 |
| 88 | positive regulation of glucose transport (GO:0010828) | 2.57569008 |
| 89 | macroautophagy (GO:0016236) | 2.57206825 |
| 90 | fatty acid homeostasis (GO:0055089) | 2.56636479 |
| 91 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.56123754 |
| 92 | ketone body metabolic process (GO:1902224) | 2.56107520 |
| 93 | serine family amino acid catabolic process (GO:0009071) | 2.56025007 |
| 94 | tryptophan metabolic process (GO:0006568) | 2.55988626 |
| 95 | synaptic vesicle maturation (GO:0016188) | 2.55836095 |
| 96 | fatty acid beta-oxidation (GO:0006635) | 2.55047886 |
| 97 | potassium ion import (GO:0010107) | 2.54796966 |
| 98 | alanine transport (GO:0032328) | 2.53317429 |
| 99 | succinate metabolic process (GO:0006105) | 2.52729948 |
| 100 | skeletal muscle adaptation (GO:0043501) | 2.52060803 |
| 101 | regulation of complement activation (GO:0030449) | 2.51722362 |
| 102 | cellular amino acid catabolic process (GO:0009063) | 2.51519010 |
| 103 | fatty acid oxidation (GO:0019395) | 2.51055926 |
| 104 | relaxation of muscle (GO:0090075) | 2.51052346 |
| 105 | nitrogen cycle metabolic process (GO:0071941) | 2.50913247 |
| 106 | positive regulation of cellular response to insulin stimulus (GO:1900078) | 2.49997076 |
| 107 | lipid oxidation (GO:0034440) | 2.49717046 |
| 108 | negative regulation of fibrinolysis (GO:0051918) | 2.49651036 |
| 109 | regulation of actin filament-based movement (GO:1903115) | 2.49337646 |
| 110 | regulation of fibrinolysis (GO:0051917) | 2.48907715 |
| 111 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.47318337 |
| 112 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 2.47238341 |
| 113 | positive regulation of lipid catabolic process (GO:0050996) | 2.46837668 |
| 114 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.46133268 |
| 115 | detection of calcium ion (GO:0005513) | 2.45924383 |
| 116 | glutamate secretion (GO:0014047) | 2.45706083 |
| 117 | protein-lipid complex remodeling (GO:0034368) | 2.45460723 |
| 118 | macromolecular complex remodeling (GO:0034367) | 2.45460723 |
| 119 | plasma lipoprotein particle remodeling (GO:0034369) | 2.45460723 |
| 120 | activation of protein kinase A activity (GO:0034199) | 2.45333881 |
| 121 | tyrosine metabolic process (GO:0006570) | 2.44644213 |
| 122 | potassium ion homeostasis (GO:0055075) | 2.43334497 |
| 123 | regulation of glucocorticoid metabolic process (GO:0031943) | 2.41551361 |
| 124 | negative regulation of lipase activity (GO:0060192) | 2.41284263 |
| 125 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.40107300 |
| 126 | carnitine metabolic process (GO:0009437) | 2.39828500 |
| 127 | cellular sodium ion homeostasis (GO:0006883) | 2.39755839 |
| 128 | cardiac muscle hypertrophy (GO:0003300) | 2.39391171 |
| 129 | monocarboxylic acid catabolic process (GO:0072329) | 2.39142726 |
| 130 | striated muscle hypertrophy (GO:0014897) | 2.39011816 |
| 131 | cell communication by electrical coupling (GO:0010644) | 2.38977173 |
| 132 | negative regulation of hormone biosynthetic process (GO:0032353) | 2.38785386 |
| 133 | fatty acid catabolic process (GO:0009062) | 2.38519332 |
| 134 | cellular response to epinephrine stimulus (GO:0071872) | 2.38475906 |
| 135 | neurotransmitter secretion (GO:0007269) | 2.38433455 |
| 136 | linoleic acid metabolic process (GO:0043651) | 2.37938561 |
| 137 | positive regulation of glycolytic process (GO:0045821) | 2.37552718 |
| 138 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.36978050 |
| 139 | adherens junction assembly (GO:0034333) | 2.36850048 |
| 140 | positive regulation of macroautophagy (GO:0016239) | 2.36836919 |
| 141 | cell communication involved in cardiac conduction (GO:0086065) | 2.36648531 |
| 142 | cell-substrate adherens junction assembly (GO:0007045) | 2.36461941 |
| 143 | focal adhesion assembly (GO:0048041) | 2.36461941 |
| 144 | embryonic process involved in female pregnancy (GO:0060136) | 2.36349920 |
| 145 | neuronal action potential propagation (GO:0019227) | 2.35907322 |
| 146 | exogenous drug catabolic process (GO:0042738) | 2.35864407 |
| 147 | clathrin coat assembly (GO:0048268) | 2.35260605 |
| 148 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.34511276 |
| 149 | phospholipid efflux (GO:0033700) | 2.34467826 |
| 150 | regulation of Rac protein signal transduction (GO:0035020) | 2.34316592 |
| 151 | negative regulation of epidermal growth factor-activated receptor activity (GO:0007175) | 2.34244932 |
| 152 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.33335645 |
| 153 | actomyosin structure organization (GO:0031032) | 2.32823980 |
| 154 | regulation of calcium ion transmembrane transport (GO:1903169) | 2.32684181 |
| 155 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 2.32684181 |
| 156 | coenzyme catabolic process (GO:0009109) | 2.32294219 |
| 157 | sarcomere organization (GO:0045214) | 2.32177327 |
| 158 | cellular glucuronidation (GO:0052695) | 2.32053857 |
| 159 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.31229803 |
| 160 | cardiac myofibril assembly (GO:0055003) | 2.30862140 |
| 161 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.30819708 |
| 162 | cholesterol efflux (GO:0033344) | 2.30214916 |
| 163 | acetyl-CoA metabolic process (GO:0006084) | 2.30066381 |
| 164 | valine metabolic process (GO:0006573) | 2.29697940 |
| 165 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.29470170 |
| 166 | regulation of synaptic vesicle transport (GO:1902803) | 2.28775687 |
| 167 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 2.27525354 |
| 168 | positive regulation of insulin receptor signaling pathway (GO:0046628) | 2.25825323 |
| 169 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.24269816 |
| 170 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 2.23496056 |
| 171 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.22798985 |
| 172 | embryonic camera-type eye morphogenesis (GO:0048596) | 2.22391766 |
| 173 | glycogen catabolic process (GO:0005980) | 2.20963090 |
| 174 | response to inactivity (GO:0014854) | 2.20742449 |
| 175 | muscle contraction (GO:0006936) | 2.20267444 |
| 176 | regulation of muscle adaptation (GO:0043502) | 2.19887360 |
| 177 | striated muscle adaptation (GO:0014888) | 2.18735569 |
| 178 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.18586907 |
| 179 | establishment of nucleus localization (GO:0040023) | 2.18422127 |
| 180 | response to epinephrine (GO:0071871) | 2.18217508 |
| 181 | protein localization to endosome (GO:0036010) | 2.17995287 |
| 182 | regulation of p38MAPK cascade (GO:1900744) | 2.15831981 |
| 183 | myoblast fusion (GO:0007520) | 2.15797032 |
| 184 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043 | 2.13868908 |
| 185 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.13125815 |
| 186 | peptidyl-threonine dephosphorylation (GO:0035970) | 2.12771416 |
| 187 | regulation of epidermal growth factor-activated receptor activity (GO:0007176) | 2.12204532 |
| 188 | nucleus localization (GO:0051647) | 2.11507135 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.51044724 |
| 2 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.44648899 |
| 3 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.04175706 |
| 4 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.80978244 |
| 5 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.75067278 |
| 6 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.45937386 |
| 7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.44658000 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.40006606 |
| 9 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.30413297 |
| 10 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 2.15384437 |
| 11 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.85047201 |
| 12 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.81711480 |
| 13 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.76646783 |
| 14 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.75906734 |
| 15 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.72142377 |
| 16 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.66060691 |
| 17 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.65552130 |
| 18 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.62943572 |
| 19 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.57266795 |
| 20 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.53614840 |
| 21 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.52862494 |
| 22 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.52558284 |
| 23 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.51676982 |
| 24 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.49029867 |
| 25 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.48753091 |
| 26 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.46037956 |
| 27 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.46037956 |
| 28 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.43325432 |
| 29 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.43210965 |
| 30 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.41793667 |
| 31 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.41607674 |
| 32 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.41604734 |
| 33 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.41521630 |
| 34 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.41129493 |
| 35 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.40368413 |
| 36 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.39761986 |
| 37 | GATA1_22025678_ChIP-Seq_K562_Human | 1.39143939 |
| 38 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.39071236 |
| 39 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.37917875 |
| 40 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.36806966 |
| 41 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.35541870 |
| 42 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.34323662 |
| 43 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.33879380 |
| 44 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.32714390 |
| 45 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.32237412 |
| 46 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.31867803 |
| 47 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.27844852 |
| 48 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.27844852 |
| 49 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.27168516 |
| 50 | * PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.25844265 |
| 51 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.25763143 |
| 52 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.24831728 |
| 53 | * CJUN_26792858_Chip-Seq_BT549_Human | 1.24640543 |
| 54 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.24534592 |
| 55 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.23339052 |
| 56 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.23218355 |
| 57 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.23025524 |
| 58 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.22350870 |
| 59 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.21219074 |
| 60 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.20761194 |
| 61 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.19964212 |
| 62 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.19964212 |
| 63 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.19035890 |
| 64 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.18883325 |
| 65 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.17804176 |
| 66 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.17213286 |
| 67 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.15630800 |
| 68 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.14984591 |
| 69 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.14321188 |
| 70 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.13791453 |
| 71 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.13509560 |
| 72 | TP53_16413492_ChIP-PET_HCT116_Human | 1.12134616 |
| 73 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.11783649 |
| 74 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.10895529 |
| 75 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.10339116 |
| 76 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.10247921 |
| 77 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.09119919 |
| 78 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.08675581 |
| 79 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.08229724 |
| 80 | RXR_22108803_ChIP-Seq_LS180_Human | 1.08085279 |
| 81 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.07262916 |
| 82 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.07075431 |
| 83 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.06813591 |
| 84 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.06250679 |
| 85 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.06176857 |
| 86 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.06009002 |
| 87 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.05897950 |
| 88 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.05338533 |
| 89 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.04953999 |
| 90 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.03860176 |
| 91 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.03724436 |
| 92 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.03238500 |
| 93 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.02768740 |
| 94 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.02439323 |
| 95 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.02426026 |
| 96 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.02327140 |
| 97 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.02026887 |
| 98 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.01941601 |
| 99 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.01889776 |
| 100 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.01573932 |
| 101 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.00812079 |
| 102 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.99882388 |
| 103 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.99496574 |
| 104 | * TP63_23658742_ChIP-Seq_EP156T_Human | 0.99362279 |
| 105 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.98772391 |
| 106 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.98738976 |
| 107 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.98243410 |
| 108 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.97520508 |
| 109 | AR_25329375_ChIP-Seq_VCAP_Human | 0.97183100 |
| 110 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.96988319 |
| 111 | STAT3_23295773_ChIP-Seq_U87_Human | 0.96733049 |
| 112 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.96727670 |
| 113 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.96679806 |
| 114 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.96200189 |
| 115 | AR_19668381_ChIP-Seq_PC3_Human | 0.95865085 |
| 116 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.95709150 |
| 117 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.95145639 |
| 118 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.94909712 |
| 119 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.94770806 |
| 120 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.94757992 |
| 121 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.93351099 |
| 122 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.93335966 |
| 123 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.92647195 |
| 124 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.92251608 |
| 125 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.90925275 |
| 126 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.90484523 |
| 127 | KDM2B_26808549_Chip-Seq_K562_Human | 0.90084826 |
| 128 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.89479857 |
| 129 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.89266437 |
| 130 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.89172428 |
| 131 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.87335314 |
| 132 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.87327465 |
| 133 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.87327465 |
| 134 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.86769986 |
| 135 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.83970054 |
| 136 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.82127237 |
| 137 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.81740712 |
| 138 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.80575194 |
| 139 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.80561990 |
| 140 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.80453478 |
| 141 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.79600532 |
| 142 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.79037217 |
| 143 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.78953215 |
| 144 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.78597868 |
| 145 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.78578604 |
| 146 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.78535974 |
| 147 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.78028896 |
| 148 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.77765754 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 4.90166157 |
| 2 | MP0005360_urolithiasis | 4.20737035 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 3.74648583 |
| 4 | MP0005365_abnormal_bile_salt | 3.73590308 |
| 5 | MP0002009_preneoplasia | 3.18580902 |
| 6 | MP0008875_abnormal_xenobiotic_pharmacok | 3.14550891 |
| 7 | MP0003252_abnormal_bile_duct | 2.81133785 |
| 8 | MP0004859_abnormal_synaptic_plasticity | 2.64616678 |
| 9 | MP0010352_gastrointestinal_tract_polyps | 2.60402140 |
| 10 | MP0010329_abnormal_lipoprotein_level | 2.52252899 |
| 11 | MP0009780_abnormal_chondrocyte_physiolo | 2.29750524 |
| 12 | MP0002837_dystrophic_cardiac_calcinosis | 2.22902894 |
| 13 | MP0004130_abnormal_muscle_cell | 2.19414528 |
| 14 | MP0000759_abnormal_skeletal_muscle | 2.07734940 |
| 15 | MP0003195_calcinosis | 2.07499827 |
| 16 | MP0000733_abnormal_muscle_development | 2.04366245 |
| 17 | MP0004043_abnormal_pH_regulation | 2.03439153 |
| 18 | MP0002822_catalepsy | 1.90051699 |
| 19 | MP0005332_abnormal_amino_acid | 1.88785387 |
| 20 | MP0002909_abnormal_adrenal_gland | 1.86399578 |
| 21 | MP0005409_darkened_coat_color | 1.82074372 |
| 22 | MP0000013_abnormal_adipose_tissue | 1.81685841 |
| 23 | MP0004510_myositis | 1.75959100 |
| 24 | MP0003635_abnormal_synaptic_transmissio | 1.74986960 |
| 25 | MP0003828_pulmonary_edema | 1.71379200 |
| 26 | MP0002118_abnormal_lipid_homeostasis | 1.68126144 |
| 27 | MP0002106_abnormal_muscle_physiology | 1.63197080 |
| 28 | MP0004233_abnormal_muscle_weight | 1.62502800 |
| 29 | MP0001666_abnormal_nutrient_absorption | 1.62032188 |
| 30 | MP0003690_abnormal_glial_cell | 1.61146387 |
| 31 | MP0003329_amyloid_beta_deposits | 1.53849026 |
| 32 | MP0005423_abnormal_somatic_nervous | 1.51905068 |
| 33 | MP0001501_abnormal_sleep_pattern | 1.50379637 |
| 34 | MP0010234_abnormal_vibrissa_follicle | 1.49468922 |
| 35 | MP0005083_abnormal_biliary_tract | 1.48533798 |
| 36 | MP0005369_muscle_phenotype | 1.48316522 |
| 37 | MP0003091_abnormal_cell_migration | 1.46875457 |
| 38 | MP0009046_muscle_twitch | 1.46177701 |
| 39 | MP0004215_abnormal_myocardial_fiber | 1.44117817 |
| 40 | MP0000751_myopathy | 1.44026105 |
| 41 | MP0002108_abnormal_muscle_morphology | 1.42904984 |
| 42 | MP0009745_abnormal_behavioral_response | 1.42138358 |
| 43 | MP0009840_abnormal_foam_cell | 1.40689162 |
| 44 | MP0008438_abnormal_cutaneous_collagen | 1.39984080 |
| 45 | MP0004270_analgesia | 1.39474726 |
| 46 | MP0008057_abnormal_DNA_replication | 1.38129389 |
| 47 | MP0005535_abnormal_body_temperature | 1.36959416 |
| 48 | MP0002064_seizures | 1.36755205 |
| 49 | MP0005275_abnormal_skin_tensile | 1.36120887 |
| 50 | MP0003705_abnormal_hypodermis_morpholog | 1.36104821 |
| 51 | MP0004019_abnormal_vitamin_homeostasis | 1.35710880 |
| 52 | MP0005670_abnormal_white_adipose | 1.34585755 |
| 53 | MP0001299_abnormal_eye_distance/ | 1.34385156 |
| 54 | MP0002090_abnormal_vision | 1.33294824 |
| 55 | MP0008961_abnormal_basal_metabolism | 1.32775101 |
| 56 | MP0004036_abnormal_muscle_relaxation | 1.32297521 |
| 57 | MP0003950_abnormal_plasma_membrane | 1.30529546 |
| 58 | MP0002063_abnormal_learning/memory/cond | 1.27341854 |
| 59 | MP0000609_abnormal_liver_physiology | 1.26243993 |
| 60 | MP0004885_abnormal_endolymph | 1.26178961 |
| 61 | MP0004145_abnormal_muscle_electrophysio | 1.25613952 |
| 62 | MP0006138_congestive_heart_failure | 1.25512465 |
| 63 | MP0005666_abnormal_adipose_tissue | 1.24867977 |
| 64 | MP0000569_abnormal_digit_pigmentation | 1.24072488 |
| 65 | MP0002896_abnormal_bone_mineralization | 1.22826471 |
| 66 | MP0003191_abnormal_cellular_cholesterol | 1.22406782 |
| 67 | MP0003300_gastrointestinal_ulcer | 1.22018573 |
| 68 | MP0001502_abnormal_circadian_rhythm | 1.21818905 |
| 69 | MP0003633_abnormal_nervous_system | 1.21249572 |
| 70 | MP0002971_abnormal_brown_adipose | 1.20872789 |
| 71 | MP0002254_reproductive_system_inflammat | 1.20616246 |
| 72 | MP0010678_abnormal_skin_adnexa | 1.19884582 |
| 73 | MP0002078_abnormal_glucose_homeostasis | 1.18601666 |
| 74 | MP0000604_amyloidosis | 1.17137163 |
| 75 | MP0002138_abnormal_hepatobiliary_system | 1.16735525 |
| 76 | MP0005167_abnormal_blood-brain_barrier | 1.16600813 |
| 77 | MP0005646_abnormal_pituitary_gland | 1.16229573 |
| 78 | MP0005551_abnormal_eye_electrophysiolog | 1.15797469 |
| 79 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.13845663 |
| 80 | MP0005623_abnormal_meninges_morphology | 1.12239764 |
| 81 | MP0002272_abnormal_nervous_system | 1.11863703 |
| 82 | MP0010368_abnormal_lymphatic_system | 1.08352117 |
| 83 | MP0003566_abnormal_cell_adhesion | 1.07755913 |
| 84 | MP0003868_abnormal_feces_composition | 1.07409467 |
| 85 | MP0010630_abnormal_cardiac_muscle | 1.07285069 |
| 86 | MP0008569_lethality_at_weaning | 1.05815270 |
| 87 | MP0005076_abnormal_cell_differentiation | 1.04984687 |
| 88 | MP0005503_abnormal_tendon_morphology | 1.04736549 |
| 89 | MP0005248_abnormal_Harderian_gland | 1.03952659 |
| 90 | MP0003806_abnormal_nucleotide_metabolis | 1.02709151 |
| 91 | MP0005319_abnormal_enzyme/_coenzyme | 1.02622205 |
| 92 | MP0001486_abnormal_startle_reflex | 1.02083425 |
| 93 | MP0002572_abnormal_emotion/affect_behav | 1.01534478 |
| 94 | MP0003045_fibrosis | 1.01493934 |
| 95 | MP0001348_abnormal_lacrimal_gland | 1.01289561 |
| 96 | MP0003283_abnormal_digestive_organ | 1.00555568 |
| 97 | MP0005187_abnormal_penis_morphology | 1.00234311 |
| 98 | MP0000750_abnormal_muscle_regeneration | 0.99863178 |
| 99 | MP0000920_abnormal_myelination | 0.99443347 |
| 100 | MP0004084_abnormal_cardiac_muscle | 0.99263415 |
| 101 | MP0005257_abnormal_intraocular_pressure | 0.98959598 |
| 102 | MP0001440_abnormal_grooming_behavior | 0.98652316 |
| 103 | MP0005375_adipose_tissue_phenotype | 0.97242398 |
| 104 | MP0009115_abnormal_fat_cell | 0.96981431 |
| 105 | MP0005620_abnormal_muscle_contractility | 0.96964203 |
| 106 | MP0000747_muscle_weakness | 0.96351260 |
| 107 | MP0005330_cardiomyopathy | 0.95353756 |
| 108 | MP0001851_eye_inflammation | 0.94700206 |
| 109 | MP0004134_abnormal_chest_morphology | 0.93856772 |
| 110 | MP0003075_altered_response_to | 0.92987975 |
| 111 | MP0002060_abnormal_skin_morphology | 0.92624955 |
| 112 | MP0002876_abnormal_thyroid_physiology | 0.92246537 |
| 113 | MP0003880_abnormal_central_pattern | 0.91394198 |
| 114 | MP0002269_muscular_atrophy | 0.90719936 |
| 115 | MP0001958_emphysema | 0.90628308 |
| 116 | MP0008874_decreased_physiological_sensi | 0.90193272 |
| 117 | MP0000003_abnormal_adipose_tissue | 0.88803772 |
| 118 | MP0003646_muscle_fatigue | 0.87747260 |
| 119 | MP0002877_abnormal_melanocyte_morpholog | 0.86647344 |
| 120 | MP0003453_abnormal_keratinocyte_physiol | 0.86451336 |
| 121 | MP0000749_muscle_degeneration | 0.86086817 |
| 122 | MP0003279_aneurysm | 0.85827412 |
| 123 | MP0001765_abnormal_ion_homeostasis | 0.83147955 |
| 124 | MP0004087_abnormal_muscle_fiber | 0.82979160 |
| 125 | MP0003634_abnormal_glial_cell | 0.81347944 |
| 126 | MP0009643_abnormal_urine_homeostasis | 0.80922858 |
| 127 | MP0004484_altered_response_of | 0.80277034 |
| 128 | MP0002067_abnormal_sensory_capabilities | 0.79935857 |
| 129 | MP0005334_abnormal_fat_pad | 0.79358943 |
| 130 | MP0004085_abnormal_heartbeat | 0.78592709 |
| 131 | MP0003879_abnormal_hair_cell | 0.77724570 |
| 132 | MP0003631_nervous_system_phenotype | 0.77338249 |
| 133 | MP0004185_abnormal_adipocyte_glucose | 0.74584992 |
| 134 | MP0005023_abnormal_wound_healing | 0.74268340 |
| 135 | MP0000230_abnormal_systemic_arterial | 0.73928129 |
| 136 | MP0002972_abnormal_cardiac_muscle | 0.73750750 |
| 137 | MP0004924_abnormal_behavior | 0.73306044 |
| 138 | MP0005386_behavior/neurological_phenoty | 0.73306044 |
| 139 | MP0002332_abnormal_exercise_endurance | 0.72960586 |
| 140 | MP0005448_abnormal_energy_balance | 0.71382598 |
| 141 | MP0000428_abnormal_craniofacial_morphol | 0.70770049 |
| 142 | MP0002734_abnormal_mechanical_nocicepti | 0.70356351 |
| 143 | MP0002166_altered_tumor_susceptibility | 0.69752135 |
| 144 | MP0001177_atelectasis | 0.69163416 |
| 145 | MP0002998_abnormal_bone_remodeling | 0.68309222 |
| 146 | MP0001879_abnormal_lymphatic_vessel | 0.66009879 |
| 147 | MP0001544_abnormal_cardiovascular_syste | 0.63515313 |
| 148 | MP0005385_cardiovascular_system_phenoty | 0.63515313 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Muscle fiber inclusion bodies (HP:0100299) | 5.43591720 |
| 2 | Nemaline bodies (HP:0003798) | 5.41052759 |
| 3 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 5.26458844 |
| 4 | Type 1 muscle fiber predominance (HP:0003803) | 4.68501314 |
| 5 | Deep venous thrombosis (HP:0002625) | 4.04108268 |
| 6 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.91272422 |
| 7 | Xanthomatosis (HP:0000991) | 3.80387743 |
| 8 | Intrahepatic cholestasis (HP:0001406) | 3.76005163 |
| 9 | Subaortic stenosis (HP:0001682) | 3.72154437 |
| 10 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.72154437 |
| 11 | Ketosis (HP:0001946) | 3.63079490 |
| 12 | Ketoacidosis (HP:0001993) | 3.55013551 |
| 13 | Hypoglycemic coma (HP:0001325) | 3.54057734 |
| 14 | Hypoalphalipoproteinemia (HP:0003233) | 3.52185012 |
| 15 | Hyperlipoproteinemia (HP:0010980) | 3.43478002 |
| 16 | Focal motor seizures (HP:0011153) | 3.20072307 |
| 17 | Complement deficiency (HP:0004431) | 3.11841925 |
| 18 | EMG: myopathic abnormalities (HP:0003458) | 3.09780480 |
| 19 | Exercise-induced myalgia (HP:0003738) | 3.02019491 |
| 20 | Asymmetric septal hypertrophy (HP:0001670) | 3.01872128 |
| 21 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.01726586 |
| 22 | Obstructive sleep apnea (HP:0002870) | 3.01040696 |
| 23 | Hypolipoproteinemia (HP:0010981) | 3.00929007 |
| 24 | Hyperammonemia (HP:0001987) | 2.99994805 |
| 25 | Prolonged partial thromboplastin time (HP:0003645) | 2.99048486 |
| 26 | Hyperglycinemia (HP:0002154) | 2.98071059 |
| 27 | Muscle fiber splitting (HP:0003555) | 2.97746090 |
| 28 | Hyperglycinuria (HP:0003108) | 2.96909531 |
| 29 | Gout (HP:0001997) | 2.91673978 |
| 30 | Abnormality of glycine metabolism (HP:0010895) | 2.81462117 |
| 31 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.81462117 |
| 32 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.81331874 |
| 33 | Round ear (HP:0100830) | 2.79269299 |
| 34 | Myoglobinuria (HP:0002913) | 2.75469644 |
| 35 | Hypobetalipoproteinemia (HP:0003563) | 2.75256038 |
| 36 | Increased variability in muscle fiber diameter (HP:0003557) | 2.72205970 |
| 37 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.71358936 |
| 38 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.71344150 |
| 39 | Epidermoid cyst (HP:0200040) | 2.67202480 |
| 40 | Abnormality of the common coagulation pathway (HP:0010990) | 2.66285939 |
| 41 | Action tremor (HP:0002345) | 2.64064207 |
| 42 | Frequent falls (HP:0002359) | 2.61642280 |
| 43 | Increased connective tissue (HP:0009025) | 2.61543742 |
| 44 | Hypoglycemic seizures (HP:0002173) | 2.61474618 |
| 45 | Visual hallucinations (HP:0002367) | 2.59125743 |
| 46 | Arterial tortuosity (HP:0005116) | 2.56713180 |
| 47 | Dysmetric saccades (HP:0000641) | 2.55279401 |
| 48 | Abnormality of the calf musculature (HP:0001430) | 2.54277676 |
| 49 | Distal arthrogryposis (HP:0005684) | 2.52926373 |
| 50 | Protrusio acetabuli (HP:0003179) | 2.51206449 |
| 51 | Neck muscle weakness (HP:0000467) | 2.47557887 |
| 52 | Skin nodule (HP:0200036) | 2.46514211 |
| 53 | Distal lower limb muscle weakness (HP:0009053) | 2.45227625 |
| 54 | Osteolytic defects of the hand bones (HP:0009699) | 2.45054929 |
| 55 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.45054929 |
| 56 | Status epilepticus (HP:0002133) | 2.44803333 |
| 57 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.42639136 |
| 58 | Overgrowth (HP:0001548) | 2.41930804 |
| 59 | Abnormality of the intrinsic pathway (HP:0010989) | 2.40809415 |
| 60 | Focal seizures (HP:0007359) | 2.39837451 |
| 61 | Vascular tortuosity (HP:0004948) | 2.39580682 |
| 62 | Ulnar deviation of the wrist (HP:0003049) | 2.38405300 |
| 63 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.37429996 |
| 64 | Exercise-induced muscle cramps (HP:0003710) | 2.37244769 |
| 65 | Hyperglycemia (HP:0003074) | 2.32142985 |
| 66 | Abnormality of purine metabolism (HP:0004352) | 2.30883307 |
| 67 | Hyperventilation (HP:0002883) | 2.26494432 |
| 68 | Aortic aneurysm (HP:0004942) | 2.25800171 |
| 69 | Febrile seizures (HP:0002373) | 2.22679565 |
| 70 | Papilledema (HP:0001085) | 2.22428139 |
| 71 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.21837958 |
| 72 | Absence seizures (HP:0002121) | 2.21641780 |
| 73 | Distal lower limb amyotrophy (HP:0008944) | 2.19508417 |
| 74 | Dysdiadochokinesis (HP:0002075) | 2.18851486 |
| 75 | Hyporeflexia of lower limbs (HP:0002600) | 2.16144759 |
| 76 | Lower limb amyotrophy (HP:0007210) | 2.15070406 |
| 77 | Intention tremor (HP:0002080) | 2.14724056 |
| 78 | Abnormal atrioventricular conduction (HP:0005150) | 2.12589106 |
| 79 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.11198535 |
| 80 | Impaired social interactions (HP:0000735) | 2.10983686 |
| 81 | Abnormal social behavior (HP:0012433) | 2.10983686 |
| 82 | Papillary thyroid carcinoma (HP:0002895) | 2.09062165 |
| 83 | Conjugated hyperbilirubinemia (HP:0002908) | 2.08494205 |
| 84 | Right ventricular cardiomyopathy (HP:0011663) | 2.07974872 |
| 85 | Spinal rigidity (HP:0003306) | 2.07962209 |
| 86 | Generalized tonic-clonic seizures (HP:0002069) | 2.07956025 |
| 87 | Scapular winging (HP:0003691) | 2.05775540 |
| 88 | Bundle branch block (HP:0011710) | 2.04997274 |
| 89 | Atonic seizures (HP:0010819) | 2.04433098 |
| 90 | Fat malabsorption (HP:0002630) | 2.01710628 |
| 91 | Myokymia (HP:0002411) | 2.01245169 |
| 92 | Hyperuricemia (HP:0002149) | 2.00316519 |
| 93 | Increased purine levels (HP:0004368) | 2.00316519 |
| 94 | EMG: neuropathic changes (HP:0003445) | 2.00021712 |
| 95 | Hypercholesterolemia (HP:0003124) | 1.99200716 |
| 96 | Global brain atrophy (HP:0002283) | 1.99020644 |
| 97 | Cubitus valgus (HP:0002967) | 1.98089649 |
| 98 | Postural instability (HP:0002172) | 1.97598674 |
| 99 | Metabolic acidosis (HP:0001942) | 1.96622407 |
| 100 | Central scotoma (HP:0000603) | 1.95916295 |
| 101 | Symptomatic seizures (HP:0011145) | 1.95647502 |
| 102 | Abnormality of complement system (HP:0005339) | 1.95553702 |
| 103 | Rimmed vacuoles (HP:0003805) | 1.94306584 |
| 104 | Difficulty running (HP:0009046) | 1.93627771 |
| 105 | Abnormality of the Achilles tendon (HP:0005109) | 1.93231521 |
| 106 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.92748567 |
| 107 | Syncope (HP:0001279) | 1.92128754 |
| 108 | Myocardial infarction (HP:0001658) | 1.92102438 |
| 109 | Menstrual irregularities (HP:0000858) | 1.90115014 |
| 110 | Sensorimotor neuropathy (HP:0007141) | 1.89455631 |
| 111 | Neurofibrillary tangles (HP:0002185) | 1.88693355 |
| 112 | Sudden death (HP:0001699) | 1.88541596 |
| 113 | Pigmentary retinal degeneration (HP:0001146) | 1.88423015 |
| 114 | Tetraplegia (HP:0002445) | 1.87636078 |
| 115 | Anxiety (HP:0000739) | 1.87345674 |
| 116 | Resting tremor (HP:0002322) | 1.86594288 |
| 117 | Atrioventricular block (HP:0001678) | 1.85742786 |
| 118 | Delayed CNS myelination (HP:0002188) | 1.85307583 |
| 119 | Supranuclear gaze palsy (HP:0000605) | 1.85283953 |
| 120 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.83983562 |
| 121 | Hemiplegia (HP:0002301) | 1.83518176 |
| 122 | Dialeptic seizures (HP:0011146) | 1.83372440 |
| 123 | Hyperkalemia (HP:0002153) | 1.82891180 |
| 124 | Abnormal gallbladder morphology (HP:0012437) | 1.82392872 |
| 125 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.82216193 |
| 126 | Poor eye contact (HP:0000817) | 1.82045241 |
| 127 | Cholelithiasis (HP:0001081) | 1.81430979 |
| 128 | Subacute progressive viral hepatitis (HP:0006572) | 1.79952281 |
| 129 | Muscle hypertrophy of the lower extremities (HP:0008968) | 1.79277047 |
| 130 | Ventricular tachycardia (HP:0004756) | 1.79267859 |
| 131 | Depression (HP:0000716) | 1.79101046 |
| 132 | Ventricular fibrillation (HP:0001663) | 1.78893848 |
| 133 | Calf muscle hypertrophy (HP:0008981) | 1.78700987 |
| 134 | Joint hemorrhage (HP:0005261) | 1.78437771 |
| 135 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.76985618 |
| 136 | Progressive cerebellar ataxia (HP:0002073) | 1.75792869 |
| 137 | Heart block (HP:0012722) | 1.75644750 |
| 138 | Pheochromocytoma (HP:0002666) | 1.75639629 |
| 139 | Myopathic facies (HP:0002058) | 1.75522453 |
| 140 | Cerebral inclusion bodies (HP:0100314) | 1.75268567 |
| 141 | Scanning speech (HP:0002168) | 1.73917247 |
| 142 | Truncal ataxia (HP:0002078) | 1.73470673 |
| 143 | Late onset (HP:0003584) | 1.73100230 |
| 144 | Proximal amyotrophy (HP:0007126) | 1.71262646 |
| 145 | Dysmetria (HP:0001310) | 1.70303322 |
| 146 | Retinal atrophy (HP:0001105) | 1.68273127 |
| 147 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.67809219 |
| 148 | Mitral stenosis (HP:0001718) | 1.66572287 |
| 149 | Rhabdomyolysis (HP:0003201) | 1.66184220 |
| 150 | Cerebral aneurysm (HP:0004944) | 1.65213766 |
| 151 | Areflexia of lower limbs (HP:0002522) | 1.64153499 |
| 152 | Persistence of primary teeth (HP:0006335) | 1.62301992 |
| 153 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.61045455 |
| 154 | Striae distensae (HP:0001065) | 1.60467820 |
| 155 | Mitral valve prolapse (HP:0001634) | 1.59856944 |
| 156 | Aortic dissection (HP:0002647) | 1.57118285 |
| 157 | Calcaneovalgus deformity (HP:0001848) | 1.56821257 |
| 158 | Hypoplasia of the iris (HP:0007676) | 1.56768839 |
| 159 | Relative macrocephaly (HP:0004482) | 1.56181614 |
| 160 | Gowers sign (HP:0003391) | 1.55581804 |
| 161 | Glucose intolerance (HP:0000833) | 1.55452418 |
| 162 | Limited hip movement (HP:0008800) | 1.55396994 |
| 163 | Foot dorsiflexor weakness (HP:0009027) | 1.55201270 |
| 164 | Malignant hyperthermia (HP:0002047) | 1.54560708 |
| 165 | Fetal akinesia sequence (HP:0001989) | 1.53436287 |
| 166 | Hip contracture (HP:0003273) | 1.52588930 |
| 167 | Ventricular arrhythmia (HP:0004308) | 1.51441802 |
| 168 | Slender build (HP:0001533) | 1.51116817 |
| 169 | Aneurysm (HP:0002617) | 1.49897765 |
| 170 | Mild short stature (HP:0003502) | 1.49659348 |
| 171 | Muscle stiffness (HP:0003552) | 1.49589249 |
| 172 | Wormian bones (HP:0002645) | 1.48803154 |
| 173 | Spondylolisthesis (HP:0003302) | 1.48689667 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K2 | 2.76470639 |
| 2 | EPHA4 | 2.69987792 |
| 3 | NTRK3 | 2.43477588 |
| 4 | LATS2 | 2.34204796 |
| 5 | INSRR | 2.32531966 |
| 6 | RIPK1 | 2.25938346 |
| 7 | FRK | 2.25911713 |
| 8 | MAP2K4 | 2.17324427 |
| 9 | BCKDK | 2.06236253 |
| 10 | TRIB3 | 2.04536341 |
| 11 | MAP3K4 | 1.99950388 |
| 12 | TRPM7 | 1.90080835 |
| 13 | SIK1 | 1.89838800 |
| 14 | PINK1 | 1.84027698 |
| 15 | MAP3K9 | 1.73391287 |
| 16 | PRPF4B | 1.70110800 |
| 17 | DAPK2 | 1.67693230 |
| 18 | NEK9 | 1.64179719 |
| 19 | KSR2 | 1.58890513 |
| 20 | MAP3K12 | 1.51831358 |
| 21 | CAMKK1 | 1.51191149 |
| 22 | LMTK2 | 1.48843015 |
| 23 | PHKG2 | 1.47499275 |
| 24 | PHKG1 | 1.47499275 |
| 25 | EEF2K | 1.44656595 |
| 26 | FGFR2 | 1.44473301 |
| 27 | CAMKK2 | 1.42275791 |
| 28 | STK38 | 1.41046169 |
| 29 | TTN | 1.40684969 |
| 30 | PRKD3 | 1.39401163 |
| 31 | ERBB3 | 1.38356136 |
| 32 | PDK3 | 1.37873717 |
| 33 | PDK4 | 1.37873717 |
| 34 | ICK | 1.37840637 |
| 35 | MAP3K7 | 1.34355481 |
| 36 | SGK3 | 1.29939297 |
| 37 | CDK12 | 1.29677991 |
| 38 | RET | 1.29626590 |
| 39 | SGK2 | 1.27276481 |
| 40 | FGFR4 | 1.25994585 |
| 41 | NTRK1 | 1.21876098 |
| 42 | PRKCH | 1.21761715 |
| 43 | PAK6 | 1.20262417 |
| 44 | MAP3K3 | 1.16108715 |
| 45 | SGK223 | 1.14928312 |
| 46 | SGK494 | 1.14928312 |
| 47 | NEK6 | 1.11458140 |
| 48 | TAOK3 | 1.11396948 |
| 49 | CAMK1G | 1.10330508 |
| 50 | PTK6 | 1.09143045 |
| 51 | CAMK1D | 1.05591405 |
| 52 | MOS | 1.03788582 |
| 53 | UHMK1 | 1.03721197 |
| 54 | FER | 1.02566141 |
| 55 | BRD4 | 1.02518381 |
| 56 | MINK1 | 1.01951550 |
| 57 | PDK2 | 1.00468803 |
| 58 | NLK | 1.00307525 |
| 59 | DMPK | 0.99914879 |
| 60 | PDGFRA | 0.99613107 |
| 61 | OBSCN | 0.99101665 |
| 62 | MET | 0.98643646 |
| 63 | WNK1 | 0.98429667 |
| 64 | JAK1 | 0.97576412 |
| 65 | PKN2 | 0.94528319 |
| 66 | TIE1 | 0.92611686 |
| 67 | PDPK1 | 0.91973940 |
| 68 | LATS1 | 0.90836009 |
| 69 | MAPK15 | 0.89928765 |
| 70 | FGFR3 | 0.89684133 |
| 71 | MAP2K7 | 0.89460597 |
| 72 | NTRK2 | 0.89413999 |
| 73 | PAK3 | 0.88448705 |
| 74 | MAP3K1 | 0.86263642 |
| 75 | STK3 | 0.86257972 |
| 76 | MAPK7 | 0.85884171 |
| 77 | ERN1 | 0.85260645 |
| 78 | STK24 | 0.85112887 |
| 79 | MARK2 | 0.82138178 |
| 80 | WNK4 | 0.81837188 |
| 81 | EPHA2 | 0.80440600 |
| 82 | BMPR2 | 0.80252966 |
| 83 | PDK1 | 0.79363682 |
| 84 | RIPK4 | 0.78817827 |
| 85 | STK11 | 0.76213440 |
| 86 | CDK5 | 0.76191252 |
| 87 | PRKAA2 | 0.75974216 |
| 88 | JAK2 | 0.75422363 |
| 89 | MAPK12 | 0.74373556 |
| 90 | MAPK10 | 0.73332532 |
| 91 | MTOR | 0.72882677 |
| 92 | MELK | 0.72655542 |
| 93 | MAP3K10 | 0.71955872 |
| 94 | SGK1 | 0.71787439 |
| 95 | STK38L | 0.70460526 |
| 96 | PRKAA1 | 0.69128245 |
| 97 | MAP2K1 | 0.69019288 |
| 98 | CAMK2G | 0.67603028 |
| 99 | TYRO3 | 0.66273112 |
| 100 | MAP3K13 | 0.65106811 |
| 101 | CDC42BPA | 0.64896874 |
| 102 | MST1R | 0.63568413 |
| 103 | CDK6 | 0.63069366 |
| 104 | CAMK2B | 0.62096299 |
| 105 | HIPK2 | 0.61776434 |
| 106 | AKT3 | 0.61643004 |
| 107 | GRK5 | 0.61484485 |
| 108 | SCYL2 | 0.61317036 |
| 109 | PRKD1 | 0.59829752 |
| 110 | MYLK | 0.59389429 |
| 111 | CAMK2A | 0.58198183 |
| 112 | CAMK4 | 0.57994027 |
| 113 | YES1 | 0.57749049 |
| 114 | PNCK | 0.56209218 |
| 115 | OXSR1 | 0.55734471 |
| 116 | PTK2 | 0.55555996 |
| 117 | CAMK2D | 0.55440698 |
| 118 | PRKCG | 0.54751597 |
| 119 | STK39 | 0.54513665 |
| 120 | CAMK1 | 0.53757517 |
| 121 | DDR2 | 0.53296500 |
| 122 | PIK3CA | 0.51532595 |
| 123 | SIK2 | 0.51119316 |
| 124 | RPS6KA3 | 0.49206210 |
| 125 | DYRK1A | 0.48616326 |
| 126 | MAP2K3 | 0.48368708 |
| 127 | PRKACG | 0.47238526 |
| 128 | RPS6KB1 | 0.46410888 |
| 129 | FGFR1 | 0.46140125 |
| 130 | PDGFRB | 0.45578205 |
| 131 | KSR1 | 0.45296554 |
| 132 | NEK1 | 0.44395508 |
| 133 | ROCK2 | 0.44313544 |
| 134 | MAP2K2 | 0.42656537 |
| 135 | PIK3CG | 0.42547470 |
| 136 | TGFBR2 | 0.41030745 |
| 137 | PRKCE | 0.41025114 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 4.03300624 |
| 2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.66933036 |
| 3 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.58833228 |
| 4 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.44097368 |
| 5 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.14867236 |
| 6 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.02424797 |
| 7 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.89719333 |
| 8 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.85689829 |
| 9 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.84632254 |
| 10 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.84416090 |
| 11 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.70474471 |
| 12 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.67648501 |
| 13 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.66828022 |
| 14 | Bile secretion_Homo sapiens_hsa04976 | 1.66196211 |
| 15 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.60084593 |
| 16 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.51561893 |
| 17 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.51424730 |
| 18 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.49140600 |
| 19 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.45119171 |
| 20 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.41149256 |
| 21 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.38294350 |
| 22 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.34136236 |
| 23 | Adherens junction_Homo sapiens_hsa04520 | 1.33567352 |
| 24 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 1.30773384 |
| 25 | Glioma_Homo sapiens_hsa05214 | 1.30634638 |
| 26 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.29562359 |
| 27 | GABAergic synapse_Homo sapiens_hsa04727 | 1.24570636 |
| 28 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.21992533 |
| 29 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.20863387 |
| 30 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.20768645 |
| 31 | Endometrial cancer_Homo sapiens_hsa05213 | 1.19985082 |
| 32 | Thyroid cancer_Homo sapiens_hsa05216 | 1.18979378 |
| 33 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.18616196 |
| 34 | Focal adhesion_Homo sapiens_hsa04510 | 1.16087662 |
| 35 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.16031131 |
| 36 | FoxO signaling pathway_Homo sapiens_hsa04068 | 1.15036284 |
| 37 | Nicotine addiction_Homo sapiens_hsa05033 | 1.12507702 |
| 38 | Insulin secretion_Homo sapiens_hsa04911 | 1.10161518 |
| 39 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.09646205 |
| 40 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.09089000 |
| 41 | Peroxisome_Homo sapiens_hsa04146 | 1.08618033 |
| 42 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.08092114 |
| 43 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.07887154 |
| 44 | Circadian entrainment_Homo sapiens_hsa04713 | 1.07636289 |
| 45 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.07595720 |
| 46 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.06518453 |
| 47 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.06013395 |
| 48 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.04125557 |
| 49 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.03472860 |
| 50 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.03000216 |
| 51 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.00708480 |
| 52 | ABC transporters_Homo sapiens_hsa02010 | 1.00398548 |
| 53 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.99721526 |
| 54 | Long-term potentiation_Homo sapiens_hsa04720 | 0.99319197 |
| 55 | Melanogenesis_Homo sapiens_hsa04916 | 0.98644963 |
| 56 | Circadian rhythm_Homo sapiens_hsa04710 | 0.98062081 |
| 57 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.97797913 |
| 58 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.97737994 |
| 59 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.96957310 |
| 60 | Salivary secretion_Homo sapiens_hsa04970 | 0.95744991 |
| 61 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.95326120 |
| 62 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.95080642 |
| 63 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.94903626 |
| 64 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.94613454 |
| 65 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.92297948 |
| 66 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.91964359 |
| 67 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.91959429 |
| 68 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.91398398 |
| 69 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.90039584 |
| 70 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.89689526 |
| 71 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.89096587 |
| 72 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.88804030 |
| 73 | Renin secretion_Homo sapiens_hsa04924 | 0.88221224 |
| 74 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.88054375 |
| 75 | Tight junction_Homo sapiens_hsa04530 | 0.87375949 |
| 76 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.86828411 |
| 77 | Morphine addiction_Homo sapiens_hsa05032 | 0.86783537 |
| 78 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.85419704 |
| 79 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.84087109 |
| 80 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.83702304 |
| 81 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.82594136 |
| 82 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.81602435 |
| 83 | Prostate cancer_Homo sapiens_hsa05215 | 0.81286023 |
| 84 | Insulin resistance_Homo sapiens_hsa04931 | 0.80194302 |
| 85 | Amoebiasis_Homo sapiens_hsa05146 | 0.79673102 |
| 86 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.79484875 |
| 87 | Histidine metabolism_Homo sapiens_hsa00340 | 0.79467565 |
| 88 | Carbon metabolism_Homo sapiens_hsa01200 | 0.78698319 |
| 89 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.77521772 |
| 90 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.75505347 |
| 91 | Olfactory transduction_Homo sapiens_hsa04740 | 0.75330385 |
| 92 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.75154056 |
| 93 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.75135658 |
| 94 | Gap junction_Homo sapiens_hsa04540 | 0.73973862 |
| 95 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.73692054 |
| 96 | Retinol metabolism_Homo sapiens_hsa00830 | 0.71329441 |
| 97 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.70000923 |
| 98 | Colorectal cancer_Homo sapiens_hsa05210 | 0.69911547 |
| 99 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.69769318 |
| 100 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.69461038 |
| 101 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.68835488 |
| 102 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.68062881 |
| 103 | Platelet activation_Homo sapiens_hsa04611 | 0.66267861 |
| 104 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.65964509 |
| 105 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.65284891 |
| 106 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.64755433 |
| 107 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.64663653 |
| 108 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.64379058 |
| 109 | Taste transduction_Homo sapiens_hsa04742 | 0.64088905 |
| 110 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.63890475 |
| 111 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.63502537 |
| 112 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.63199404 |
| 113 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.63061660 |
| 114 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.61321047 |
| 115 | Endocytosis_Homo sapiens_hsa04144 | 0.61042859 |
| 116 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.60850023 |
| 117 | Lysine degradation_Homo sapiens_hsa00310 | 0.60160395 |
| 118 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.60098469 |
| 119 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.59961538 |
| 120 | Cocaine addiction_Homo sapiens_hsa05030 | 0.59783274 |
| 121 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.59702687 |
| 122 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.59291263 |
| 123 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.57749460 |
| 124 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.57384920 |
| 125 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.57312527 |
| 126 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.57241441 |
| 127 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.57135768 |
| 128 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.56490205 |
| 129 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.56325278 |
| 130 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.55390403 |
| 131 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.54951545 |
| 132 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.54337904 |
| 133 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.54332817 |
| 134 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.53646379 |
| 135 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.52144114 |
| 136 | Melanoma_Homo sapiens_hsa05218 | 0.51880763 |
| 137 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.51824193 |
| 138 | Long-term depression_Homo sapiens_hsa04730 | 0.50161264 |
| 139 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.49923480 |
| 140 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.49760771 |
| 141 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.48489900 |
| 142 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.48061992 |
| 143 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.46757653 |
| 144 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.46337772 |
| 145 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.45707363 |
| 146 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.45266273 |
| 147 | Prion diseases_Homo sapiens_hsa05020 | 0.44934537 |
| 148 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.44769867 |

